Quote | InMed Pharmaceuticals Inc. (NASDAQ:INM)
Last: | $0.252 |
---|---|
Change Percent: | 13.2% |
Open: | $0.263 |
Close: | $0.252 |
High: | $0.265501 |
Low: | $0.25 |
Volume: | 617,804 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | InMed Pharmaceuticals Inc. (NASDAQ:INM)
InMed Pharmaceuticals (NASDAQ: INM) , a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is announcing that Dr. David G. Morgan, PhD, a renowned leader in neurodegenerative disease, has joined its scientific advisory board (&...
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the research, development, manufacturing, and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced the addition ...
Message Board Posts | InMed Pharmaceuticals Inc. (NASDAQ:INM)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $INM 38% v22,1M c1.46 f3,328M H1.68 ML.92 | znewcar1 | investorshangout | 03/20/2023 10:43:43 PM |
NetworkNewsWire: NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Peer-Reviewed Study Res | NetworkNewsWire | investorshangout | 03/13/2023 8:57:12 PM |
NetworkNewsWire: NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financ | NetworkNewsWire | investorshangout | 02/21/2023 8:43:52 PM |
znewcar1: $INM 36% v4,4M c2.30 f1,589M H2.41 ML1.23 | znewcar1 | investorshangout | 01/10/2023 10:04:53 PM |
NetworkNewsWire: NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestone | NetworkNewsWire | investorshangout | 01/10/2023 8:35:09 PM |
News, Short Squeeze, Breakout and More Instantly...
InMed Pharmaceuticals Inc. Company Name:
INM Stock Symbol:
NASDAQ Market:
Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in today's pre-market trading following first-quarter results. Tesla posted weaker-than-expec...
InMed Pharmaceuticals (NASDAQ: INM) , a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is announcing that Dr. David G. Morgan, PhD, a renowned leader in neurodegenerative disease, has joined its scientific advisory board (&...
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the research, development, manufacturing, and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced the addition ...